Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler.

Researchers evaluated the safety and efficacy of neuromuscular electric stimulation therapy in the reduction of knee osteoarthritis-related pain, stiffness, and function.

The Quell neuromodulation device has received the FDA De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia.

Researchers developed and validated a diagnostic prediction model to distinguish between juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome.

Researchers investigated whether intra-articular coinjection with hypertonic dextrose improves hyaluronic acid therapy outcomes for patients with knee osteoarthritis.

The approval was based on data from the phase 2/3 SELECT-AXIS 1 and the phase 3 SELECT-AXIS 2 trials.

Laboratory analyses revealed certain Artri and Ortiga products contain undeclared drug ingredients.

Researchers assessed data from a subgroup of patients with rheumatoid arthritis, based on their health status, 3 years after diagnosis.

Three distinct chronic pain phenotypes were identified in knee osteoarthritis.

Unilateral plantar heel pain intensity is affected by demographic, clinical, and psychological variables.